Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 332
Selected: 0
NCT IDTitle
NCT03927105Nivolumab and the Antagonistic CSF-1R Monoclonal Antibody Cabiralizumab (BMS-986227) in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma
NCT02037230Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the Pancreas
NCT00115739Trial Evaluating Gleevec in Patients With Anaplastic Thyroid Carcinoma
NCT00141726Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant
NCT00556452Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan Regimen
NCT07673614Transcranial Direct Current Stimulation for the Treatment of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors
NCT00982995Palonosetron for the Treatment of Nausea and Vomiting in Terminally Ill Patients
NCT07443943A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS Trial
NCT00555477Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure
NCT00724568Combination Study of Revlimid®, Velcade® Dexamethasone and Doxil® (RVDD)for Newly Diagnosed Multiple Myeloma
NCT01209962A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor Response
NCT03287050Anti-PD(L)1 and SBRT in the Treatment of Advanced, Platinum-Refractory Urothelial Carcinoma
NCT03242915Pembrolizumab Plus Chemotherapy in NSCLC With Targetable Genetic Alterations After Progression on Targeted Agents
NCT00570531Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma
NCT07481344SunBeast: Evaluating UV Protective Behaviors and Education Interventions Among Ultrarunners
NCT05867667Cardiac Rehabilitation to Improve Breast Cancer Outcomes
NCT02118636Observational Study to Evaluate Mechanisms of Aromatase Inhibitor Associated Musculoskeletal Symptoms
NCT03287063Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma
NCT02613598Dose Escalation Study to Determine the Maximum Tolerated Dose of the Combination of Ruxolitinib and Bortezomib in Patients With Relapsed or Refractory Lymphoma
NCT04754399Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias
NCT07094685Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer
NCT03556904FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)
NCT03562507Multi-center Trial of ESK981 in Combination With Nivolumab in Patients With Metastatic Renal Cell Carcinoma
NCT01428219Trial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to Bone
NCT01073436Discontinuation of Imatinib Mesylate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With Interferon-Alpha
NCT00143871Study of Rituximab Plus High-Dose Chemotherapy Non-Hodgkin's Lymphoma
NCT04268134Altering Lipids for Tolerance of Aromatase Inhibitor Therapy
NCT00141700Study of Rituximab Plus High-Dose Chemotherapy Poor Prognosis Non-Hodgkin's Lymphoma
NCT00176787Radiation Therapy With Capecitabine in Rectal Cancer
NCT04272645Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer
NCT00480857Salvage Radiation Therapy and Taxotere for PSA Failure After Radical Prostatectomy
NCT00904345Study of Radiation (RT) Concurrent With Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (SCC)
NCT00150995Tetrathiomolybdate in Hormone Refractory Prostate Cancer
NCT01210027A Study of Radiation Toxicity in the Liver Using MRI-Based Perfusion
NCT04140162Phase 2 Study With Minimal Residual Disease (MRD) Driven Adaptive Strategy in Treatment for Newly Diagnosed Multiple Myeloma (MM) With Upfront Daratumumab-based Therapy
NCT02679586Imaging Biomarker for Early Detection of Treatment Efficacy During Breast Cancer Neoadjuvant Chemotherapy
NCT04552418Intestinal Microbiome Modification With Resistant Starch in Patients Treated With Dual Immune Checkpoint Inhibitors
NCT04574856Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma
NCT01700036A Pilot Study of Alpha-1-Antitrypsin (AAT) in Steroid Refractory Acute Graft vs Host Disease
NCT00161278Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression Profiling
NCT03208712Radium-223 and Atezolizumab in Patients With Urothelial Carcinoma With Bone Metastases Who Have Had Disease Progression After Platinum-Based Chemotherapy
NCT00593866Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic Cancer
NCT01975597Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer
NCT00141713The Use of Etanercept (Enbrel®) in the Treatment of Acute Graft-Versus-Host Disease
NCT06941324Solution-Focused Brief Therapy for Support of Psychological Distress in Adolescent and Young Adult Cancer Survivors
NCT02045381Optimization of MRI for Radiation Therapy
NCT00959998Acupressure for Post-Treatment Cancer Fatigue
NCT00843375Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
NCT00616109Sunitinib Maintenance Therapy After Induction Platinum-Based Chemotherapy in Patients With ES-SCLC
NCT00603057Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer